{"id":2838,"date":"2017-01-31T17:43:20","date_gmt":"2017-01-31T17:43:20","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=20247"},"modified":"2017-01-31T17:43:20","modified_gmt":"2017-01-31T17:43:20","slug":"medical-marijuana-inc-subsidiary-hempmeds-mexico-recognizes-one-year-anniversary-first-rsho-x-import-permit","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2017\/01\/31\/medical-marijuana-inc-subsidiary-hempmeds-mexico-recognizes-one-year-anniversary-first-rsho-x-import-permit\/","title":{"rendered":"Medical Marijuana, Inc. Subsidiary HempMeds\u00ae Mexico Recognizes One-Year Anniversary of First RSHO-X\u2122 Import Permit"},"content":{"rendered":"
SAN DIEGO<\/span>, Jan. 31, 2017<\/span>\u00a0 —\u00a0Medical Marijuana, Inc.<\/u> (OTC PINK: MJNA), the first publicly traded cannabis company in the United States<\/span>, is proud to announce the progress made by subsidiary HempMeds\u00ae Mexico upon the one-year anniversary of the first-ever import permit for RSHO-X<\/a>\u2122 into Mexico<\/span>.<\/p>\n HempMeds\u00ae Mexico<\/span> is the first company to receive government import permits<\/a> for the cannabidiol (CBD) oil product RSHO-X<\/a>\u2122 via the Mexican Health Department, COFEPRIS. The decision by COFEPRIS ushered in a historic newfound relationship between the company and Mexico.<\/a><\/p>\n The first permits issued for usage of the CBD product were for two Mexico<\/span> girls Alina Maldonado Montes de Oca and Maria Paula<\/a>. The plight of parents attempting to acquire CBD hemp oil products for their suffering children was profiled in the documentary Crisis<\/i><\/a>, which features HempMeds\u00ae Mexico<\/span> and the legal battle for access to CBD products.<\/p>\n HempMeds\u00ae Mexico<\/span> hosted the country’s first-ever Doctors Symposium<\/a> in Mexico City<\/span> aimed at educating medical professionals on the benefits of CBD and the proper way to prescribe it. The company has since partaken in numerous events like the First National Symposium<\/a> to meet with political and advocacy leaders<\/a>. These events serve as a means of community outreach<\/a> and promote further access<\/a> to CBD hemp oil products amongst citizens of Mexico<\/span>, and have helped educate thousands of doctors and patients alike on the company’s products.<\/p>\n Another family close to HempMeds\u00ae Mexico<\/span> is that of Grace of the Por Grace Foundation. Grace’s father, Raul Elizalde<\/span>, started the Por Grace Foundation to further access to CBD for Grace and others like his daughter. The premier cannabidiol advocacy group works closely with HempMeds\u00ae Mexico<\/span> to help interested patients navigate the process to access CBD. Raul was invited to join President Pe\u00f1a Nieto on stage in April to give an impassioned speech about the effects of cannabinoids on his daughter before the Mexican President announced<\/a> that country would be pursuing a more compassionate stance on the medical use of marijuana in the country.<\/p>\n These initial permits have enabled product access for more than 126 million people in Mexico<\/a>. As the demand and popularity of the company’s products have begun to soar, new appointments to leadership were also introduced. In August of 2016, Dion Markgraaff was named President of HempMeds\u00ae Mexico<\/a> in order to sustain and promote the growth of the company’s development in the country.<\/p>\n “We are proud to see the expanding presence of RSHO-X\u2122 within Mexico<\/span>,” said Medical Marijuana, Inc.<\/a> CEO, Dr. Stuart Titus<\/span>. “A short year ago, we were providing our product to two patients in Mexico<\/span>. Now, we are pleased to see that over 200 people have begun to experience the value of what our company has to offer.”<\/p>\n Dr. Titus added, “HempMeds\u00ae Mexico<\/span> serves an invaluable purpose to those in Mexico<\/span> who suffer needlessly in silence. We expect and fully commit to continued growth in our southern neighbor so that we can strengthen the lives and livelihoods of those we serve.”<\/p>\n HempMeds\u00ae RSHO-X\u2122 THC-free CBD oil was also at the center of a recent study on the effects of CBD and epilepsy. Renowned Mexican physician Dr. Carlos G. Aguirre Velazquez<\/span> recently announced the results<\/a> of a new survey conducted on children with refractory epilepsy.<\/p>\n HempMeds\u00ae Mexico<\/span>, which established itself in Monterrey, Nuevo Leon<\/span>, seeks to continue working with Mexican health authorities in beginning clinical studies on CBD products in 2017.<\/p>\n HempMeds\u00ae Mexico<\/span> also worked to open several new Latin American markets this past year, expanding efforts into Chile<\/a>, Colombia<\/a>, and Paraguay<\/a>. As the tide of opinion regarding medical marijuana continues to change in Latin America<\/span>, HempMeds\u00ae Mexico<\/span> and Medical Marijuana, Inc. will work alongside activists and patients in efforts to bring access to those who need it most.<\/p>\n If you want understand more about HempMeds\u00ae Mexico’s<\/span> outreach and growing leadership team click HERE<\/a> or HERE<\/a>.<\/p>\n About HempMeds\u00ae Mexico<\/span> About Medical Marijuana, Inc. To see Medical Marijuana, Inc.’s video statement, click here<\/u><\/a>. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop<\/u><\/a> for discounted products.<\/p>\n FORWARD-LOOKING DISCLAIMER FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE LEGAL DISCLOSURE CONTACT: SAN DIEGO, Jan. 31, 2017\u00a0 —\u00a0Medical Marijuana, Inc. (OTC PINK: MJNA), the first publicly traded cannabis company in the United States, is proud to announce the progress made by subsidiary HempMeds\u00ae Mexico upon the one-year anniversary of the first-ever import permit for RSHO-X\u2122 into Mexico. HempMeds\u00ae Mexico is the first company to receive government import […]<\/p>\n","protected":false},"author":1,"featured_media":2099,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[137,2],"tags":[181],"class_list":["post-2838","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hempmeds-mexico","category-press-releases","tag-hempmeds-mexico"],"yoast_head":"\n
\n<\/b>HempMeds<\/u><\/a>\u00aeMexico<\/u><\/a> is a Mexico<\/span>-based company that made history by being the first company to receive a COFEPRIS federal government import permit for the cannabis product RSHO-X\u2122 for a medical indication. HempMeds\u00ae Mexico<\/span> plans to work directly with the Mexican government to safely and legally provide access to CBD hemp oil products. For more information, please review the company’s website at: http:\/\/www.hempmeds.mx<\/u><\/a>.<\/p>\n
\n<\/b>Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com<\/u><\/a>.<\/p>\n
\n<\/i><\/b>This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and\/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.<\/i><\/p>\n
\n<\/i><\/b>These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.<\/i><\/p>\n
\n<\/i><\/b>Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.<\/i><\/p>\n
\n<\/u><\/b>Public Relations Contact:
\n<\/b>Andrew Hard<\/span>
\nChief Executive Officer
\nCMW Media
\nP. 888-829- 0070
\nandrew.hard@cmwmedia.com<\/a>
\nwww.cmwmedia.com<\/u><\/a> \t<\/p>\n","protected":false},"excerpt":{"rendered":"